Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences FDA to weigh easing limits on unproven peptides promoted by RFK Jr. BPC 157 Rapid Pro 500mcg Pure Prescriptions The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Warning Letter to Neil R. Feins, M.D. 2009 05 20 Circare FDA Issues Flurry of Warning Letters to Companies Making Unapproved Claims about CBD and Delta 8 Products Buchanan Ingersoll & Rooney PC